In summary, the impact of RANBP2 on the SUMOylation of p53 is found in lung cancer, which diminishes the regulatory control exerted by tumor suppressor factors over cellular apoptosis, thereby culminating in tumorigenesis (Fig. 4). Here, RANBP2 is linked to neoplasm.